Losartan pregnancy category

Losartan: Pregnancy Category: D: Description: Losartan may cause fetal harm and should not be used during pregnancy. Discontinue as soon as possible if pregnancy is detected. Potential Risks: Losartan has been associated with fetal toxicity and developmental abnormalities. Recommendations

Amlodipine: Pregnancy Category C; Losartan: Pregnancy Category D. The safety of amlodipine in human pregnancy has not been established. In animal studies

Pregnancy: Category C (first trimester); Category D (second and third trimester). Losartan that act on the angiotensin system can cause injury and death to

Pregnancy Category D. The risk to the fetus increases if Losartan Potassium is administered during the second or third trimesters of pregnancy. It is not known

Pregnancy Category D. The risk to the fetus increases if Losartan Potassium is administered during the second or third trimesters of pregnancy. It is not known

Advice and warnings for the use of Losartan (Cozaar) during pregnancy. FDA Pregnancy Category D - Positive evidence of risk.

When pregnancy is detected, discontinue losartan as soon as possible. Drugs Pharmacologic Category. Angiotensin II Receptor Blocker

pregnancy. Losartan and hydrochlorothiazide falls into category D. It has been shown that use of losartan and hydrochlorothiazide in

PREGNANCY CATEGORIES OF DRUGS Pregnancy Category C : Studies in women and animals are. PREGNANCY CATEGORIES OF DRUGS Pregnancy Category